Regents Gate Capital LLP Makes New $269,000 Investment in The Clorox Company (NYSE:CLX)

Regents Gate Capital LLP purchased a new position in The Clorox Company (NYSE:CLXFree Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 1,658 shares of the company’s stock, valued at approximately $269,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of CLX. Brooklyn Investment Group boosted its position in Clorox by 163.8% during the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after acquiring an additional 95 shares in the last quarter. Prospera Private Wealth LLC purchased a new stake in shares of Clorox during the 3rd quarter worth $27,000. Continuum Advisory LLC boosted its position in Clorox by 300.0% during the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock valued at $30,000 after purchasing an additional 138 shares in the last quarter. Carolina Wealth Advisors LLC purchased a new position in Clorox in the third quarter valued at about $48,000. Finally, Friedenthal Financial bought a new position in Clorox in the third quarter worth about $49,000. 78.53% of the stock is currently owned by institutional investors.

Clorox Trading Up 0.6 %

Shares of Clorox stock opened at $148.51 on Monday. The stock has a market cap of $18.38 billion, a PE ratio of 40.58, a price-to-earnings-growth ratio of 2.52 and a beta of 0.42. The firm has a fifty day moving average price of $161.06 and a 200 day moving average price of $158.88. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.37. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.62.

Clorox (NYSE:CLXGet Free Report) last released its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, beating analysts’ consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter last year, the company posted $2.16 earnings per share. Equities research analysts predict that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be paid a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.29%. Clorox’s payout ratio is 133.33%.

Analyst Ratings Changes

A number of brokerages have recently issued reports on CLX. StockNews.com downgraded shares of Clorox from a “buy” rating to a “hold” rating in a research report on Sunday, January 5th. JPMorgan Chase & Co. upped their price target on Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a research report on Tuesday, February 4th. Royal Bank of Canada reissued a “sector perform” rating and issued a $150.00 price objective on shares of Clorox in a research report on Thursday, January 30th. DA Davidson reduced their target price on Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 5th. Finally, Wells Fargo & Company raised their price target on Clorox from $157.00 to $161.00 and gave the stock an “equal weight” rating in a report on Tuesday, February 4th. Four analysts have rated the stock with a sell rating, eleven have given a hold rating and one has issued a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $158.21.

Get Our Latest Stock Report on CLX

About Clorox

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Recommended Stories

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.